ENCOMPASS HEALTH CORP's ticker is EHC and the CUSIP is 29261A100. A total of 387 filers reported holding ENCOMPASS HEALTH CORP in Q2 2018. The put-call ratio across all filers is 0.70 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $212,964 | -0.8% | 3,171 | 0.0% | 0.03% | +3.8% |
| Q2 2023 | $214,708 | -25.6% | 3,171 | -34.3% | 0.03% | -23.5% |
| Q4 2022 | $288,583 | +26.6% | 4,825 | -4.5% | 0.03% | +13.3% |
| Q3 2022 | $228,000 | -19.4% | 5,050 | 0.0% | 0.03% | -11.8% |
| Q2 2022 | $283,000 | -21.2% | 5,050 | 0.0% | 0.03% | -8.1% |
| Q1 2022 | $359,000 | +6.5% | 5,050 | -2.1% | 0.04% | +8.8% |
| Q4 2021 | $337,000 | -12.9% | 5,160 | 0.0% | 0.03% | -19.0% |
| Q3 2021 | $387,000 | -7.6% | 5,160 | -3.9% | 0.04% | -6.7% |
| Q2 2021 | $419,000 | -8.3% | 5,368 | -3.9% | 0.04% | -13.5% |
| Q1 2021 | $457,000 | -1.1% | 5,583 | -0.0% | 0.05% | -5.5% |
| Q4 2020 | $462,000 | +26.2% | 5,585 | -1.0% | 0.06% | +12.2% |
| Q3 2020 | $366,000 | +56.4% | 5,640 | +88.0% | 0.05% | +28.9% |
| Q3 2018 | $234,000 | +15.3% | 3,000 | 0.0% | 0.04% | +5.6% |
| Q2 2018 | $203,000 | – | 3,000 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JANA PARTNERS LLC | 2,001,897 | $150,222,000 | 11.74% |
| JET CAPITAL INVESTORS L P | 855,100 | $64,167,000 | 10.95% |
| Davide Leone & Partners Investment Co Ltd. | 735,308 | $55,178,000 | 4.23% |
| Kent Lake Capital LLC | 110,000 | $8,254,000 | 3.55% |
| REINHART PARTNERS, LLC. | 604,274 | $53,309,000 | 2.71% |
| AREX Capital Management, LP | 74,000 | $5,553,000 | 2.59% |
| RK Capital | 179,800 | $13,492,000 | 2.55% |
| Orchard Capital Management, LLC | 108,266 | $8,124,000 | 2.44% |
| BARINGTON CAPITAL GROUP, L.P. | 24,200 | $1,816,000 | 1.88% |
| Sivik Global Healthcare LLC | 100,000 | $7,504,000 | 1.79% |